DEA Schedule III Registration is Open Now
All State-Licensed Medical Cannabis Operators
Dispensaries, cultivators, manufactureres, distributors and analytical laboratories lincenced under a state-licensed medical cannabis program can now apply to hold a federal DEA registration under the Controlled Substancs Act. Operatores who apply by June 26, 2026 are covered under the clean-slate rule (safe harbor). We help you understand what that means for your operation and get your application right.
The 60-Day Expedited Window Is Closing
On April 28, 2026, the DEA moved state-licensed medical marijuana to Schedule III. You have until June 26, 2026 to file and maintain Fast-Track status, interim operational protection, and 280E tax relief.
What Vatic Delivers
We bring DEA federal licensing expertise to the cannabis rescheduling moment with a track record no generalist consulting firm can match.
SOP Audit & Gap Analysis
We assess your existing SOPs against the full list of DEA Schedule III functional requirements and identify exactly which work instructions are missing or insufficient, and which the client can address independently.
SOP Development
Where gaps are identified, Vatic develops the missing SOP work instructions. We direct clients to areas they can complete themselves and take over where specialist expertise is required.
Physical Security Gap Assessment
DEA compliance requires documented evidence: floor plans, equipment specifications, personnel flow diagrams, material flow pathways, and storage configuration review against 21 CFR section 1301.72. Vatic conducts a real gap assessment producing the documentation DEA requires for Section 5 and Section 7 compliance.
Personnel & Liability Compliance
Full guidance on compiling required ownership and personnel histories. We help clients understand and accurately answer all liability disclosure questions including controlled substance conviction history, prior DEA registration actions, and state licence revocation history.
7-Section Application Navigation
Expert guidance through all sections of the DEA online registration portal: drug code selection, liability disclosures, supplier and customer verification, and submission confirmation.
Post-Licensing & Expansion Support
Vatic supports renewals, inventory submissions, DEA audits, site inspection preparation, ongoing DEA communications, and export opportunities as new federal licence categories open.
Free GAP Analysis With Every Consultation
Book a free Zoom consultation and Vatic will analyse the gaps between your state medical marijuana licence and the new federal DEA Schedule III requirements at no cost.
Free GAP Analysis
When you book a free Zoom consultation with Vatic, we provide a complimentary analysis identifying the gaps between your state medical marijuana licence requirements and the new federal DEA Schedule III Controlled Substances Act registration criteria. No cost. No obligation.
Compliance Scorecard
Once you engage Vatic's paid services, we produce a detailed Compliance Scorecard for the relevant sections of the DEA Schedule III registration form. The Scorecard maps your existing state licence documentation against each DEA requirement, showing exactly where you comply, partially comply, or have a gap to close.
The Right Client for Vatic Services
We work exclusively with state-licensed medical marijuana operators navigating DEA Schedule III registration.
✓ Qualifying Clients
Active state medical marijuana licence holders
Dispensaries, cultivators, processors, distributors, and analytical labs with valid state medical licences.
Operators with SOP or security documentation gaps
Any operator whose existing state documentation does not fully satisfy DEA Section 5 and Section 7 federal compliance requirements.
Operators who have already filed
Filing is not the end. Vatic supports clients who need help preparing for DEA site inspections, responding to agency correspondence, or managing ongoing DEA compliance obligations after submission.
Multi-licence operators
Dispensary clients with manufacturing, distribution, or processing licences who need support for additional DEA drug codes as new federal forms become available.
✗ Non-Qualifying Operators
How Vatic Engages
A scoped, deadline-focused engagement designed to get your application submitted accurately and on time.
Free Consultation
Confirm licence status, identify drug codes, assess SOP and security documentation readiness, and review liability disclosure requirements.
Scope & Proposal
Fixed-fee engagement scoped to your specific gaps. Vatic charges only for work the client cannot complete independently.
Application Preparation
SOP development, security documentation, personnel records, and full 7-section review. Weeks 1 through 3.
Submission by June 26
Guided portal submission at mmapplication.diversion.dea.gov with confirmation documentation for interim operational protection.
What Vatic Delivers
Full-spectrum DEA Schedule III registration support from initial gap assessment through to submission, and beyond.
DEA Schedule III Registration
Vatic provides a cost-optimized, deadline-focused engagement for state-licensed medical marijuana operators. We scope our services to the gaps the client cannot close independently.
Free GAP Analysis When You Book a Consultation
Vatic provides a complimentary GAP analysis comparing the DEA Schedule III Controlled Substances Act registration requirements with your specific state medical marijuana or cannabis licensing obligations. This analysis is free when you book a Zoom consultation with Vatic.
When you engage Vatic's paid services following the consultation, we produce a Compliance Scorecard for the relevant sections of the DEA Schedule III dispensary registration form. The Scorecard documents the specific discrepancies between your existing regulatory documentation and the DEA requirements under the new rescheduling rules, giving you a clear roadmap to federal compliance.
Core Service Modules
SOP Audit & Gap Analysis
We assess your existing SOPs against the full list of DEA Schedule III functional requirements. We identify exactly which work instructions are missing or insufficient, and which the client can address independently.
SOP Development
Where gaps are identified, Vatic develops the missing SOP work instructions. We direct clients to areas they can complete themselves and take over where specialist expertise is required.
Physical Security Gap Assessment & Documentation
State security requirements may appear similar to DEA standards on paper, but federal compliance requires documented evidence: floor plans, equipment specifications, personnel flow diagrams, material flow pathways, and storage configuration review. Vatic conducts a real gap assessment and produces the documentation DEA requires for Section 5 and Section 7 compliance, including a mock on-site inspection service where needed.
Personnel Compliance Screening
Guidance on compiling personal details and disciplinary histories for all owners, directors, officers, stockholders, and controlled substance handlers. We help clients understand all liability disclosure requirements before submitting.
7-Section Application Navigation
Expert guidance through all sections of the DEA online portal: drug code selection (7362 / 7353 / 7386), liability disclosures, supplier and customer verification, and submission confirmation.
280E Tax Relief Positioning
State medical operators are now exempt from Section 280E tax disallowance. We help you understand your eligibility and position you for maximum benefit before connecting you with qualified tax counsel.
Why Credentials Matter for Section 6 Liability Disclosures
The DEA application's liability section asks about controlled substance convictions, prior DEA registration actions, state licence revocations, and history of unauthorized controlled substance activity for every owner, director, officer, and stockholder. Answering these questions incorrectly or incompletely is the most common cause of application rejection. Nigel Boast's legal background and federal controlled substance licensing experience make Vatic uniquely qualified to guide clients through this section accurately.
SOP Requirements: DEA Schedule III vs. State Medical Licence
The table below identifies the full list of SOP functional areas required for DEA Schedule III compliance. The gap between state SOP coverage and DEA requirements is Vatic's primary service area.
| SOP Functional Area | DEA Schedule III Required | Corresponding Responsibility | State Medical Licence Covers | Vatic Service Required |
|---|---|---|---|---|
| Ordering controlled substances | ✓ | Registrant must verify supplier DEA registration before each order | Partial | Review |
| Receiving controlled substances | ✓ | Registrant bears responsibility for verifying incoming shipment against DEA order records | Partial | Review |
| Inventory management & biennial inventory | ✓ | Registrant must maintain perpetual records meeting DEA format requirements | Partial | Review |
| Storage & vault/safe specifications | ✓ | Registrant responsible for documented compliance with 21 CFR section 1301.72 specifications | Partial | Gap Assessment + Docs |
| Security protocols (surveillance, access, alarms) | ✓ | Registrant must document all physical security measures with floor plans, equipment specs, and personnel/material flow | Partial | Full Assessment Required |
| Dispensing procedures | ✓ | Registrant responsible for federal-compliant dispensing records and patient verification | Yes (state-specific) | Client-Led |
| Distribution to DEA-registered customers | ✓ | Registrant must verify DEA registration of all customers prior to distribution | No | Vatic Develops |
| Destruction of controlled substances | ✓ | Registrant responsible for DEA-compliant destruction records and authorized methods | Partial | Review |
| Theft & loss reporting (DEA Form 106) | ✓ | Registrant must report to DEA within 1 business day of discovery; Form 106 within 45 days | No (DEA-specific) | Vatic Develops |
| Customer / supplier DEA registration verification | ✓ | Registrant bears full corresponding responsibility for verifying all trading partner registrations | No (DEA-specific) | Vatic Develops |
| Corresponding responsibility | ✓ | Registrant must have documented processes establishing individual accountability across all controlled substance activities | No (DEA-specific) | Vatic Develops |
| Maintenance of records (DEA format) | ✓ | Registrant responsible for records accessible to DEA inspection at any time | Partial | Review |
| INCB / Single Convention reporting (manufacturers) | Manufacturers only | Registrant responsible for annual statistical returns under Single Convention obligations | No | Advisory Only |
Post-Licensing Services
DEA Audits & Inspections
Pre-inspection preparation, mock inspection walkthroughs, and response support.
Licence Renewals
Annual DEA registration renewal management and compliance updates.
Inventory & Quota Submissions
ARCOS reporting, biennial inventory, and quota application support.
Ongoing DEA Communication
Agency correspondence management, response drafting, and regulatory liaison.
Upcoming DEA Licensing Categories
The DEA rescheduling order is opening new federal licence categories in the coming weeks. Vatic is positioned to support operators across all emerging categories as DEA forms become available.
Manufacturers
State-licensed cannabis manufacturers processing naturally derived delta-9-THC. Additional INCB Single Convention reporting obligations apply. DEA Form pending.
Distributors
Licensed cannabis distributors moving medical marijuana between DEA-registered entities. Supplier and customer verification SOPs are critical for this category.
Processors & Extractors
Operators producing cannabis extracts and concentrate products. Extract-specific drug codes and SOP requirements differ from dispensary registration.
Analytical Laboratories
State-licensed cannabis testing labs. DEA registration enables testing of Schedule III material with full federal compliance documentation.
International & Export Opportunities
DEA Schedule III registration is the foundational federal authorization that enables US medical marijuana operators to explore international markets. Vatic provides advisory services on the regulatory pathway to export.
Schedule III as the Export Foundation
US operators holding a DEA Schedule III registration are operating within the framework of the Single Convention on Narcotic Drugs (1961). This places them within the international regulatory architecture that governs lawful movement of controlled substances across borders, the prerequisite for any export programme.
Single Convention Compliance
The 1961 Single Convention on Narcotic Drugs governs the international movement of cannabis. DEA Schedule III registration places US operators within this framework. INCB annual statistical returns are required for manufacturers.
DEA Import/Export Permits
21 CFR Part 1312 governs import and export of Schedule III controlled substances. Each shipment requires a DEA permit. Vatic advises on the permit application process and documentation requirements.
Destination Country Compliance
Export viability depends on the destination country's regulatory framework. Vatic's cross-border regulatory experience including Health Canada compliance work positions us to advise on Canada-US corridors specifically.
Market Assessment
Identifying viable export markets, assessing import country regulatory requirements, and developing the compliance infrastructure required for a sustainable export programme.
DEA Expertise
Applied to Cannabis Rescheduling
Nigel Boast
Nigel Boast is the Founder and Principal of Vatic Global Advisors and Boast Consult Inc., with over 25 years of regulatory affairs, compliance, and product development experience spanning the pharmaceutical, cannabis, and biotech sectors.
Nigel has obtained over 45 cannabis licences across regulatory frameworks with a 100% approval rate. His practice covers DEA and Health Canada federal registration, GMP compliance, SOP development, controlled substance security, and manufacturing commercialization. His legal background (LLB with Post Graduate Law) makes him uniquely qualified to guide clients through the liability disclosure sections of the DEA application, the most consequential and frequently mishandled element of the Schedule III filing.
He holds a Health Canada Security Clearance and has deep experience in C-Suite leadership support, Quality Management Systems, and the federal regulatory processes that govern controlled substances on both sides of the US-Canada border.
Justin Abril
Justin Abril's federal compliance practice is built on direct, firsthand experience navigating one of the most demanding regulatory processes in U.S. controlled substance law. Over a six-year engagement with the DEA, Justin served as primary liaison in securing one of only seven Schedule I marihuana licences issued nationally for cultivation and manufacturing, a process conducted without established industry precedent and requiring the development of every compliance system, procedure, and protocol from the ground up.
As the founding compliance and operations executive, Justin oversaw the full conversion of a vacant commercial building into a 100,000 square foot, federally compliant Schedule I controlled substance manufacturing facility with an operational footprint of approximately 68,000 square feet covering cultivation, processing, and manufacturing. He designed and implemented an extensive camera and access control infrastructure across a 10-acre perimeter, engineered to meet DEA physical security standards and restrict personnel access to the minimum required for each controlled process. He authored 60+ controlled substance standard operating procedures, trained approximately 20 personnel and an internal security team on DEA compliance protocols, and established the quality assurance and control systems required to meet strict cGMP standards.
Following licensure, Justin managed all ongoing federal registration obligations including continuous ARCOS inventory reporting and annual DEA quota applications since 2022, maintaining a 100% success rate across seven consecutive DEA audits and inspections. He also accomplished what is believed to be a first of its kind under DEA authorization: the completion of Schedule I marihuana import and export transactions, coordinating physical shipments with licensed partners in Canada, the United Kingdom, and Australia. Justin built the international compliance framework from scratch, developing working knowledge of each country's regulatory requirements, international treaty obligations, and supply agreement structures across seven countries including Germany, Greece, Switzerland, and Turkey.
Prior to his compliance career, Justin served as a Police Sergeant with the Department of Defense at Camp Pendleton, commanding a 45-person federal law enforcement team and managing complex multi-agency federal investigations for eight years.
Start Your DEA Registration Today
Book a free Zoom consultation and receive a complimentary GAP analysis comparing DEA Schedule III Controlled Substances Act requirements with your state medical marijuana licensing obligations. Filing deadline: June 27, 2026.
Free Consultation Request
What to Expect
Free GAP Analysis Included
Every Zoom consultation includes a complimentary GAP analysis comparing DEA Schedule III requirements with your state medical marijuana licensing obligations.
Compliance Scorecard
Once you engage Vatic, we produce a detailed Compliance Scorecard mapping your existing documentation against each DEA requirement, showing exactly where gaps exist.
Fixed-Fee Proposal
Scope is limited to what you actually need. Vatic charges for gaps, not for work you can complete independently.
Already Filed?
If you have already submitted your DEA application, Vatic can still help with site inspection preparation, agency correspondence management, and ongoing compliance support.